Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Aug 29, 2012
Dr. Craig McDonald explains the Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, which was created to conduct studies of treatments for neurological diseases through partnerships with academia, private foundations, and industry. McDonald says the network is designed to expand the National Institute of Neurological Disorders and Stroke's (NINDS) capability to test promising new therapies, increase the efficiency of clinical trials before embarking on larger studies, and respond quickly as new opportunities arise to test promising treatments for people with neurological disorders. For more information, visit http://www.ucdmc.ucdavis.edu/pmr/rese...